|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.38 AUD | +1.33% |
|
-2.56% | -7.32% |
| Apr. 15 | Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3% | MT |
| Apr. 09 | Orthocell Revenue Soars 19% to AU$1.61 Million in Q1 | MT |
Orthocell Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 1.41 million compared to AUD 0.846859 million a year ago. Net loss was AUD 5.23 million compared to AUD 4.06 million a year ago.
Basic loss per share from continuing operations was AUD 0.026 compared to AUD 0.021 a year ago. Diluted loss per share from continuing operations was AUD 0.026 compared to AUD 0.021 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.32% | 51.19M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ORTHOCELL LIMITED 
